100 related articles for article (PubMed ID: 2995261)
1. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives.
Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y
Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of the indole alkaloid tumor promoter teleocidins.
Irie K; Hagiwara N; Tokuda H; Koshimizu K
Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947
[TBL] [Abstract][Full Text] [Related]
3. Effects of synthetic analogues of teleocidin, indolactam-V, on the differentiation of murine pre-adipose cells.
Sato M; Hiragun A; Shudo K
Cancer Lett; 1985 Jan; 25(3):261-9. PubMed ID: 3918784
[TBL] [Abstract][Full Text] [Related]
4. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of (-)-6-n-octyl-indolactam-V, a new potent analogue of the tumor promoter (-)-indolactam-V.
Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H
Biosci Biotechnol Biochem; 1998 Aug; 62(8):1568-73. PubMed ID: 9757563
[TBL] [Abstract][Full Text] [Related]
6. The biological activity of hydrogen peroxide. III. Induction of Epstein-Barr virus via indirect action, as compared with TPA and teleocidin.
Oya Y; Tonomura A; Yamamoto K
Int J Cancer; 1987 Jul; 40(1):69-73. PubMed ID: 3036721
[TBL] [Abstract][Full Text] [Related]
7. Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA.
Yamamoto H; Katsuki T; Hinuma Y; Hoshino H; Miwa M; Fujiki H; Sugimura T
Int J Cancer; 1981 Aug; 28(2):125-9. PubMed ID: 6274809
[TBL] [Abstract][Full Text] [Related]
8. Biological activities and cellular uptake studies of fluorescent derivatives of indole alkaloid tumor promoter teleocidin.
Irie K; Okuno S; Koshimizu K; Tokuda H; Nishino H; Iwashima A
Int J Cancer; 1989 Mar; 43(3):513-9. PubMed ID: 2538401
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin.
Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T
Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181
[TBL] [Abstract][Full Text] [Related]
10. The metabolism of indole alkaloid tumor promoter, (-)-indolactam V, which has the fundamental structure of teleocidins, by rat liver microsomes.
Hagiwara N; Irie K; Tokuda H; Koshimizu K
Carcinogenesis; 1987 Jul; 8(7):963-5. PubMed ID: 3109758
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells.
Stein J; Stahn S; Neudörfl JM; Sperlich J; Schmalz HG; Teusch N
ChemMedChem; 2018 Jan; 13(2):147-154. PubMed ID: 29195005
[TBL] [Abstract][Full Text] [Related]
12. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M
Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic Formation of Indolactam Scaffold by C-N Bond-Forming Cytochrome P450 Oxidases in Teleocidin Biosynthesis.
Morita I; Mori T; Abe I
Chemistry; 2021 Feb; 27(9):2963-2972. PubMed ID: 32996659
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
Lin JC; Smith MC
Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
[TBL] [Abstract][Full Text] [Related]
15. Suppression by protein kinase C inhibitors of tumor promoter enhancement of Epstein-Barr virus-induced growth transformation.
Kinoshita T; Takahashi I; Kobayashi E; Tamaoki T; Irie K; Koshimizu K; Osato T
Anticancer Res; 1990; 10(4):1051-4. PubMed ID: 1696445
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship in potentially anti-tumor promoting benzalacetone derivatives, as assayed by the epstein-barr virus early antigen activation.
Motohashi N; Yamagami C; Tokuda H; Okuda Y; Ichiishi E; Mukainaka T; Nishino H; Saito Y
Mutat Res; 2000 Jan; 464(2):247-54. PubMed ID: 10648911
[TBL] [Abstract][Full Text] [Related]
17. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.
Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H
Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus early antigen induction in Raji cells by Chinese medicinal herbs.
Zeng Y; Zhong JM; Mo YK; Miao XC
Intervirology; 1983; 19(4):201-4. PubMed ID: 6305871
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of 3-nitro-2,4,6-trihydroxybenzamides on Epstein-Barr virus early antigen induction.
Honda I; Tokuda H; Kozuka M; Yoneyama K; Nishino H; Iwashima A; Shibagaki M; Noma M; Takahashi N; Yoshida S
Cancer Lett; 1991 Aug; 59(2):83-8. PubMed ID: 1653108
[TBL] [Abstract][Full Text] [Related]
20. Activation of the EBV-cycle and aggregation of human blood lymphocytes by the tumor promoters teleocidin, lyngbyatoxin A, aplysiatoxin and debromoaplysiatoxin.
Eliasson L; Kallin B; Patarroyo M; Klein G; Fujiki H; Sugimura T
Int J Cancer; 1983 Jan; 31(1):7-11. PubMed ID: 6299973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
